Evidence map›Paper›PMID 34913059›Full record

ArticlePediatrics2022

Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019.

Marianne E Yee, Kristina W Lai, Nitya Bakshi, Joanna K Grossman, Preeti Jaggi, Alexander Mallis, Yun F Wang, Robert C Jerris, Peter A Lane, Inci Yildirim

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Marianne E YeeAflac Cancer and Blood Disorders Center.
Kristina W LaiAflac Cancer and Blood Disorders Center.
Nitya BakshiAflac Cancer and Blood Disorders Center.
Joanna K GrossmanAflac Cancer and Blood Disorders Center.
Preeti JaggiDepartments of Pediatrics.
Alexander MallisAflac Cancer and Blood Disorders Center.
Yun F WangPathology and Laboratory Medicine, School of Medicine.
Robert C JerrisDepartment of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.
Peter A LaneAflac Cancer and Blood Disorders Center.
Inci YildirimDepartments of Pediatrics.
Center for Cancer and Blood Disorders · USChildren's Healthcare of Atlanta · USEmory University · USGrady Health System · US

Funding

STUDYING INTRA-INDIVIDUAL PAIN VARIABILITY IN SICKLE CELL DISEASE AND RESOLUTION OF PAIN AFTER HEMATOPOIETIC CELL TRANSPLANT: A NOVEL MODEL SYSTEM TO ELUCIDATE MECHANISMS OF TRANSITION TO CHRONIC PAINK23HL140142 · NHLBI · YALE UNIVERSITY · PI BAKSHI, NITYA · 2018 to 2022
$899k
Kinetics of Red Blood Cell Clearance in Chronically Transfused Children with Sickle Cell DiseaseK23HL146904 · NHLBI · EMORY UNIVERSITY · PI YEE, MARIANNE ELAINE MCPHERSON · 2020 to 2024
$853k
NHLBI NIH HHS K23 HL140142NHLBI NIH HHS K23 HL146904
6 · The paper itself

Abstract

backgroundChildren with sickle cell disease (SCD) are at increased risk for bloodstream infections (BSIs), mainly because of functional asplenia. Immunizations and antibiotic prophylaxis have reduced the prevalence of invasive bacterial infections, but contemporary analysis of BSI in children with SCD is limited.

methodsWe conducted a retrospective cohort study of children aged <18 years with SCD who had blood cultures collected at our institution from 2010 to 2019 to identify BSI. Probable contaminant organisms were identified and not included as BSI. We calculated the annual incidence of BSI at our institution with 95% confidence intervals (CIs) and used multivariate logistic regression to evaluate associations.

resultsThere were 2694 eligible patients with 19 902 blood cultures. Excluding repeated cultures and contaminant cultures, there were 156 BSI episodes in 144 patients. The median age at BSI was 7.5 years. The average incidence rate of BSI was 0.89 per 100 person-years (95% CI 0.45-1.32). The most common pathogens were Streptococcus pneumoniae (16.0%), Streptococcus viridans group (9.0%), Escherichia coli (9.0%), Staphylococcus aureus (7.7%), Bordetella holmesii (7.7%), Haemophilus influenzae (7.1%), and Salmonella species (6.4%). Odds of BSI were higher with sickle cell anemia genotypes (odds ratio [OR] 1.88; 95% CI 1.20-2.94) and chronic transfusions (OR 2.66; 95% CI 1.51-4.69) and lower with hydroxyurea (OR 0.57; 95% CI 0.39-0.84).

conclusionsBSI remains a risk for children with SCD. Overall incidence, risk factors, and spectrum of pathogens are important considerations to guide prevention and empirical treatment of suspected infection in SCD.

Indexed as

AdolescentAnemia, Sickle CellChildFemaleGenotypeGeorgiaHumansIncidenceMaleRetrospective StudiesRisk FactorsSepsis

Identifiers

PMID34913059
PMCPMC8959248
OpenAlexW4200335445

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.